| scholarly article | Q13442814 |
| P50 | author | Helen Rees | Q28822985 |
| Richard J. Hayes | Q38640707 | ||
| Gita Ramjee | Q42571276 | ||
| Mitzy Gafos | Q56849236 | ||
| Saidi H Kapiga | Q58252410 | ||
| Anatoli Kamali | Q72432449 | ||
| P2093 | author name string | Deborah Ford | |
| Andrew Nunn | |||
| Sheena McCormack | |||
| Angela M Crook | |||
| Maureen Chisembele | |||
| P2860 | cites work | Hormonal contraception and HIV: an unanswered question | Q85047229 |
| Research on hormonal contraception and HIV | Q87160476 | ||
| Marginal structural models and causal inference in epidemiology | Q29619287 | ||
| Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches | Q30671120 | ||
| Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. | Q33640212 | ||
| A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the Microbicides Development Programme. | Q33640226 | ||
| Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection | Q33779655 | ||
| Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling | Q34123283 | ||
| PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial | Q34138687 | ||
| The progestin-only contraceptive medroxyprogesterone acetate, but not norethisterone acetate, enhances HIV-1 Vpr-mediated apoptosis in human CD4+ T cells through the glucocorticoid receptor. | Q34712821 | ||
| Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study | Q35699938 | ||
| The implementation and appraisal of a novel confirmatory HIV-1 testing algorithm in the Microbicides Development Programme 301 Trial (MDP301). | Q36226878 | ||
| Living with uncertainty: acting in the best interests of women | Q36410468 | ||
| Comparison of dynamic treatment regimes via inverse probability weighting | Q36447516 | ||
| Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk | Q36888158 | ||
| Constructing inverse probability weights for marginal structural models | Q37321459 | ||
| Microbicides Development Programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention | Q37415011 | ||
| Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence. | Q38122873 | ||
| Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa | Q39232370 | ||
| Next steps for research on hormonal contraception and HIV. | Q43568092 | ||
| Hormonal contraception and the risk of HIV acquisition among women in South Africa | Q43678639 | ||
| Progesterone implants enhance SIV vaginal transmission and early virus load | Q45767734 | ||
| Research on hormonal contraception and HIV - Authors' reply. | Q46765269 | ||
| Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. | Q55042020 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1810-1817 | |
| P577 | publication date | 2014-05-16 | |
| P1433 | published in | Human Reproduction | Q5937357 |
| P1476 | title | Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial | |
| P478 | volume | 29 |
| Q37409664 | An updated systematic review of epidemiological evidence on hormonal contraceptive methods and HIV acquisition in women |
| Q47557200 | Application of causal inference methods in the analyses of randomised controlled trials: a systematic review |
| Q37628108 | Association between injectable progestin-only contraceptives and HIV acquisition and HIV target cell frequency in the female genital tract in South African women: a prospective cohort study |
| Q64062005 | Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection |
| Q39265015 | Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa |
| Q33552342 | Could misreporting of condom use explain the observed association between injectable hormonal contraceptives and HIV acquisition risk? |
| Q89438252 | Depot medroxyprogesterone acetate administration alters immune markers for HIV preference and increases susceptibility of peripheral CD4+ T cells to HIV infection |
| Q64115828 | Effects of three long-acting reversible contraceptive methods on HIV target cells in the human uterine cervix and peripheral blood |
| Q21144588 | Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis |
| Q30660068 | Hormonal contraceptive use and women's risk of HIV acquisition: a meta-analysis of observational studies |
| Q27311833 | Increases in Endogenous or Exogenous Progestins Promote Virus-Target Cell Interactions within the Non-human Primate Female Reproductive Tract |
| Q40515915 | Levonorgestrel in contraceptives and multipurpose prevention technologies: does this progestin increase HIV risk or interact with antiretrovirals? |
| Q89664038 | Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1 |
| Q31014284 | Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial |
| Q92380763 | Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women |
| Q52683139 | Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies. |
| Q35172396 | Progesterone-based intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1 mRNA expression. |
| Q90223732 | Protective Effect of Probiotic Bacteria and Estrogen in Preventing HIV-1-Mediated Impairment of Epithelial Barrier Integrity in Female Genital Tract |
| Q39381539 | The role of progestins in HIV acquisition in young women |
| Q37693973 | Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda |
Search more.